These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12835132)

  • 1. Aripiprazole.
    Harv Ment Health Lett; 2003 Jun; 19(12):6. PubMed ID: 12835132
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
    Evcimen YA; Evcimen H; Holland J
    Am J Psychiatry; 2007 Sep; 164(9):1436-7. PubMed ID: 17728431
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
    Crismon ML; DeLeon A; Miller AL
    Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
    [No Abstract]   [Full Text] [Related]  

  • 4. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?
    DeQuardo JR
    J Clin Psychiatry; 2004 Jan; 65(1):132-3. PubMed ID: 14976671
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
    Koener B; Hermans E; Maloteaux JM; Jean-Jean A; Constant EL
    Am J Psychiatry; 2007 Sep; 164(9):1437-8. PubMed ID: 17728432
    [No Abstract]   [Full Text] [Related]  

  • 6. Tardive dyskinesia due to aripiprazole: report of 2 cases.
    Lungu C; Aia PG; Shih LC; Esper CD; Factor SA; Tarsy D
    J Clin Psychopharmacol; 2009 Apr; 29(2):185-6. PubMed ID: 19512985
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperprolactinemia with aripiprazole: understanding the paradox.
    Saraf G; Behere RV; Venkatasubramanian G; Rao NP; Varambally S; Gangadhar BN
    Am J Ther; 2014; 21(3):e80-1. PubMed ID: 22357167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
    Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
    [No Abstract]   [Full Text] [Related]  

  • 11. Focus on aripiprazole.
    Green B
    Curr Med Res Opin; 2004; 20(2):207-13. PubMed ID: 15006016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.
    Narita M; Takei D; Shiokawa M; Tsurukawa Y; Matsushima Y; Nakamura A; Takagi S; Asato M; Ikegami D; Narita M; Amano T; Niikura K; Hashimoto K; Kuzumaki N; Suzuki T
    Eur J Pharmacol; 2008 Dec; 600(1-3):105-9. PubMed ID: 18955042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitation associated with aripiprazole initiation.
    Lea JW; Stoner SC; Lafollette J
    Pharmacotherapy; 2007 Sep; 27(9):1339-42. PubMed ID: 17723088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aripiprazole as "dopamine sensitivity stabilizer"].
    Tadokoro S
    Nihon Rinsho; 2013 Apr; 71(4):684-8. PubMed ID: 23678600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.
    Schieber FC; Boulton DW; Balch AH; Croop R; Mallikaarjun S; Benson J; Carlson BX
    Hum Psychopharmacol; 2009 Mar; 24(2):145-52. PubMed ID: 19132712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole. OPC 14597.
    Drugs R D; 1999 Jul; 2(1):47-8. PubMed ID: 10610282
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats.
    Burda K; Czubak A; Kus K; Nowakowska E; Ratajczak P; Zin J
    Pharmacol Rep; 2011; 63(4):898-907. PubMed ID: 22001977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole: quite possibly a new type of antipsychotic.
    Kutscher EC
    S D J Med; 2003 Apr; 56(4):139-40. PubMed ID: 12728840
    [No Abstract]   [Full Text] [Related]  

  • 19. Worsening of psychosis with aripiprazole.
    Eatt J; Varghese ST
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E20. PubMed ID: 24763776
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrinsic activity of aripiprazole is not 30% of dopamine, but only about 6% under ideal antipsychotic therapy.
    Hamamura T; Kodama M; Harada T
    J Clin Psychiatry; 2008 May; 69(5):863-4; author reply 864-5. PubMed ID: 18681765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.